Diseases, Conditions, Syndromes

Osteopontin, a protein not always as bad as it is made out to be

Metabolic fatty liver disease, known as non-alcoholic fatty liver disease, is one of the most common causes of liver disease in Western countries and covers a spectrum of disorders. It is strongly associated with metabolic ...

Diseases, Conditions, Syndromes

Fatty liver disease despite a normal weight examined

Non-alcoholic fatty liver disease (NAFLD) had long been thought to be a liver disease afflicting obese patients, while recent evidence has shown that non-obese individuals can be equally affected by NAFLD. In a new study, ...

Medical research

Transplantable lab-grown organs move a step closer

Biologists and bioengineers at EPFL have designed a new method for growing simplified human mini-livers. Their process is a potentially important breakthrough in the quest for transplantable lab-grown tissues. In the shorter ...

Diseases, Conditions, Syndromes

Alcohol fuels surge in chronic liver disease

Alcohol's popularity and its central place in socializing in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

Diseases, Conditions, Syndromes

Novel antisense drug shows promise in slowing fatty liver disease

Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively ...

Obstetrics & gynaecology

NAFLD in pregnancy increases risks for mother and baby

Non-alcoholic fatty liver disease (NAFLD) in pregnancy has nearly tripled over the past ten years. It increases risks for both mother and baby, including hypertensive complications of pregnancy, bleeding after delivery, and ...

page 14 from 21